An individual approach to feline diabetes care: a case report and literature review
Achieving insulin independence is emerging as a realistic therapeutic goal in the management of feline diabetes mellitus.
The management of an 11-year-old spayed female Burmese cat presenting with diabetes mellitus after corticosteroid administration is described. Remission was achieved after the frequency of insulin administration was increased to four times a day, and supported by intensive home blood glucose monitoring and a high protein, low carbohydrate diet.
Owners are important collaborators in feline diabetes care and, with intensive home monitoring, more frequent insulin treatment may lead to remission without hypoglycemia. More frequent insulin injections than recommended in the literature may be necessary to achieve glycemic control and used as an alternative to a longer-acting insulin.
KeywordsDiabetes mellitus Remission Insulin therapy Home glucose monitoring
Feline diabetes mellitus is characterised by insulin resistance and impaired insulin secretion, and its prevalence is increasing, partly due to lifestyle factors, including indoor confinement and physical inactivity [1, 2, 3]. Lean cats with low insulin sensitivity are predisposed to impaired glucose tolerance with weight gain . Increasing weight is a risk factor for diabetes [1, 3, 5], along with advancing age [1, 5, 6] and sex, with diabetes being more common in neutered male cats [1, 3, 5, 6]. Burmese cats in the UK are 3.7 times more likely to develop diabetes than non-pedigree cats . Similar observations have been made of Burmese cats in Australia [7, 8] and Sweden ; and recent studies suggest that this is due to dysregulation of lipid metabolism in this breed [10, 11]. A recent pilot study suggests involvement of a major gene locus in diabetes in Burmese cats .
Diabetes remission rates exceeding 60 % have been reported in cats receiving pharmacological and dietary management [13, 14, 15], and remission may be achieved in cats that have ketoacidosis at presentation . Insulin and diet are the mainstays of therapy. It is reported that the remission rate is higher on glargine compared to porcine lente insulin . A recent systematic review has reported that successful remission rates vary considerably and that remission is associated with a variety of insulin types and protocols . The duration of insulin action of glargine, although reported to be on average longer than lente , may vary from animal to animal . There is an anecdotal report of effective management in two diabetic cats using multiple daily injections of a mixture of short acting and long acting insulin .
While insulin independence is a realistic therapeutic goal in feline diabetes, remission is dependent on achieving glycemic control quickly  and, without intensive monitoring, high insulin doses increase the risk of hypoglycemia. We present a case of an 11-year old spayed Burmese cat that presented with diabetes after steroid treatment for skin allergy. Control of blood glucose was not achieved using a low carbohydrate diet plus the recommended twice-daily treatment with either insulin lente or glargine, with the total dose limited by the risk of hypoglycemia. A more frequent insulin regimen using glargine was used successfully.
From day 77, when the cat was on a total daily dose of 1 unit of glargine, glucose concentrations were mostly within the reference range. However it seemed that insulin was still required to achieve euglycemia, and that requirements to achieve euglycaemia were increasing. On day 95, on 0.5 units q6 h glargine, glucose concentrations were 6–8 mmol/L and a fructosamine concentration was 280 µmol/L, in the middle of the reference range. On day 98 it was noted that the weight had increased to 3.9 kg with a body condition score of 6. The total caloric intake was thereafter restricted to a maximum of 75 g wet and 25 g dry food (Purina DM) and physical activity was increased by playing with the cat several times a day. Within 5 days insulin was withdrawn and 1 month later, a visit was made to the local veterinary surgeon. The fructosamine was 271 µmol/L. Over the following 4 years later the cat has remained insulin-independent and, when glucose concentrations are measured (occasionally) these ranged from 4.6 to 5.1 mmol/L.
This case demonstrates that changing the frequency of insulin injections can be considered as an alternative to changing to a longer-acting insulin and offered to owners of cats not achieving control on twice daily regimes. Hypoglycemia is one of the biggest concerns for owners of cats with diabetes  and is associated with larger doses of insulin . It is possible that the risk of hypoglycemia could be avoided by dividing the insulin dosage and administering at more frequent intervals. Alternatively some cats may respond to changing to an insulin that is longer-acting, for example changing from lente to glargine, or from glargine to detemir . These insulins may have a shorter duration of action than in humans . Detemir has less variability in duration of action between cats and in some cats, the duration of action is longer than for glargine . The phase of relative hyperglycemia observed in this case report was interpreted by the owner as representing a significant counter-regulatory response, even in the absence of documented hypoglycemia, and responded by reducing the insulin dose. In retrospect, looking at the pattern of blood glucose levels and considering the intensive monitoring, it is unlikely that frank hypoglycaemia was responsible for the paradoxical increase in blood glucose. An alternative explanation is that decreases in insulin dose may have contributed to the phenomenon.
The decline in β cell function in feline diabetes is believed to be a consequence of glucotoxity, that is initially reversible but later irreversible . Glucocorticoid administration is a well-documented risk factor for feline diabetes and may well have contributed to the onset of hyperglycemia by decreasing insulin sensitivity in this case. Cats treated with corticosteroid in the 6 months prior to diabetes diagnosis are more likely to go into remission than those that did not receive steroids . In this case the product delivered was an insoluble steroid ester and hence its effect could well have lasted for up to 6 weeks. However, once insulin resistance had improved, appropriate insulin dosing appeared to be important to resolve glucotoxicity for recovery of β cell function. Other reported risk factors were also present in this cat, including advancing age, indoor confinement and physical inactivity, and Burmese breed [7, 8, 9]. Although diets that are low in carbohydrate have an important place in management of the disease [13, 27], when fed ad libitum they may lead to greater weight gain than diets that are relatively high in carbohydrate and low in fat , and may have contributed to the weight gain in this case because they are also high in fat .
The owner of this particular case, a physician herself, took a great deal of responsibility in day-to-day management decisions. A recent feline diabetes-associated quality of life survey indicated that the areas reported as most negatively impacting included “owner wanting more control” . In humans, interventions that involve patient collaboration are particularly important in improving self-care behaviours, quality of life and empowerment, to such an extent that the International Diabetes Federation has deemed that diabetes self-management education is considered a right for all those with, or at risk of, diabetes . It is similarly recommended that owners of cats with diabetes should be informed of the options available to them, including the benefits of tight glucose control and home capillary glucose monitoring.
ML was involved in the clinical handling of this case and drafted the manuscript. ES was involved in discussion regarding the clinical handling of the case. All authors contributed to critically revise the manuscript and gave final approval. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Publication charges for this article were funded by the research platform Future Animal Health and Welfare at the Swedish University of Agricultural Sciences.
About this supplement
This article has been published as part of Acta Veterinaria Scandinavica Volume 58 Supplement 1, 2016: Animal Obesity—causes, consequences and comparative aspects: current research. The full contents of the supplement are available online at http://actavetscand.biomedcentral.com/articles/supplements/volume-58-supplement-1.
Availability of data and materials
The authors’ confirm that materials described in the manuscript will be freely available to any scientist wishing to use them for non-commercial purposes.
Consent for publication
The animal owner gave informed consent for publication.
Ethics approval and consent to participate
Ethics approval was not needed because all the information was obtained from clinical diagnosis. The animal owner gave informed consent to participation.
- 23.Laflamme D. Development and validation of a body condition score system for cats: a clinical tool. Feline Pract. 1997;25:13–8.Google Scholar
- 30.International Diabetes Federation. Position statement: self-management education. 2011. http://www.idf.org/education/position-statements/self-management-education. Accessed 20 Sep 2015.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.